P04.49
Newborn affected by maternal use of other drugs of addiction
Clinical Classification Guidelines
Excludes Type 2
- newborn affected by maternal anesthesia and analgesia (P04.0)
- withdrawal symptoms from maternal use of drugs of addiction (P96.1)
Medical Intelligence & Overview
ICD-10 code P04.49 refers to newborns who are affected by maternal use of drugs of addiction other than commonly recognized substances like opioids or alcohol. This condition occurs when a mother uses certain addictive substances during pregnancy, which can impact the health and development of her baby. Recognizing and understanding this condition is crucial for healthcare providers and families to ensure appropriate care and intervention for affected newborns.
Causes & Symptoms
Clinical Causes: Maternal use of various addictive substances during pregnancy such as cocaine, methamphetamines, hallucinogens, or other illicit drugs. Use of prescription medications with addictive potential without medical supervision. Substance dependence or addiction in the mother leading to continued drug use during pregnancy. Cross-generational transmission of drug dependency effects through placental transfer.
Key Symptoms: Low birth weight Preterm birth Irritability or excessive crying Poor feeding or difficulty feeding Respiratory issues such as rapid breathing or irregular breathing patterns Sleep disturbances Seizures or tremors Muscle rigidity or tone abnormalities Possible congenital anomalies depending on the substance used
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of maternal history, clinical observation of the newborn, and laboratory testing. Healthcare providers may conduct toxicology screening of the infant's blood, urine, or meconium (early stool) to detect the presence of specific drugs. Additionally, assessments of physical health, neurological function, and growth parameters help in evaluating the extent of the impact.
Treatment Protocols: Monitoring vital signs and respiratory function Providing nutritional support, including IV fluids if necessary Managing withdrawal symptoms with medications and comfort measures Supporting neurological development through appropriate environmental stimuli Addressing feeding difficulties with specialized feeding strategies Providing ongoing developmental support and early intervention services Collaborating with multidisciplinary teams to address ongoing health and developmental needs
Clinical Advice & FAQs
Billing Guidance
Is P04.49 a billable ICD-10 code?
Yes, P04.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.49?
Clinical documentation must specify the nature of Newborn affected by maternal use of other drugs of addiction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference